News
Drug company shares are down amid President Donald Trump’s assault on the industry, but some in Congress see value.
Chemistry falls under the umbrella of natural sciences, alongside other fields like biology, geology and physics. Chemistry ...
22hon MSN
Best-in-class innovations in workplace AI are highlighted by Newsweek 's AI Impact Award winners in the workplace categories: ...
21h
MedPage Today on MSNNovel GLP-1/GIP Agent Led to Weight Loss With Once-Monthly DosingCHICAGO -- An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in ...
1h
Zacks Investment Research on MSNPfizer to Face Several Headwinds: Can It Successfully Navigate Them?Pfizer PFE is likely to encounter several headwinds in the next couple of years that can hurt its sales and profits, the ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
The company’s strategy focuses on steadily increasing its dividend, reinvesting in the business with strong financial returns, and carrying out value-driven share buybacks.
Mean body weight reductions after 24 weeks ranged from 8.2% to 10.3% in the MDR-001 cohorts, versus 2.5% in the placebo arm.
Cambridge, Massachusetts-based Nuvalent has reported the results of its phase 1/2 ARROS-1 trial of zidesamtinib in previously ...
Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...
CAR T-cell therapy targeting B-cell maturation antigen (BCMA) has become a game changer for patients with relapsed or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results